MDT
NYSEMedtronic plc
Technology · Electromedical & Electrotherapeutic Apparatus
Research view
Fundamentals · SEC EDGAR · FY 2026-04-24
Revenue & Earnings — fiscal year
$31.7B
2022
$31.2B
2023
$32.4B
2024
$33.5B
2025
$36.4B
2026
Snapshot
SEC EDGAR · FY 2026-04-24Revenue$36.4B
Net Income$4.8B
Gross Profit—
Oper Income$6.5B
EPS (dil)$3.73
Rev/sh$28.41
FCF/sh$4.24
Book/sh$39.12
Gross M—
Oper M17.8%
Profit M13.3%
FCF M14.9%
ROE9.7%
ROA5.2%
ROIC7.1%
R&D/Rev—
Rev Y/Y8.4%
Rev 3Y CAGR5.2%
EPS Y/Y3.3%
EPS 3Y CAGR9.8%
FCF 3Y CAGR5.8%
Payout75%
Div/sh$2.84
Shs Chg Y/Y-0.1%
Current Ratio2.13
Quick Ratio1.62
Debt/Eq0.48
Int Coverage9.0×
Net Debt$22.0B
Total Debt$23.9B
Cash & Eq$1.9B
Total Assets$93.0B
Oper CF$7.3B
Capex$1.9B
Free CF$5.4B
Buybacks$1.0B
Equity$50.1B
Liabilities$43.0B
Shs Outstand1.28B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $31.7B | $31.2B | $32.4B | $33.5B | $36.4B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $5.8B | $5.5B | $5.1B | $6.0B | $6.5B |
| Net Income | $5.1B | $3.8B | $3.7B | $4.7B | $4.8B |
| Diluted EPS | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 |
| Operating Cash Flow | $7.3B | $6.0B | $6.8B | $7.0B | $7.3B |
| Free Cash Flow | $6.0B | $4.6B | $5.2B | $5.2B | $5.4B |
COMMUNITY · $MDT0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.